Literature DB >> 2859836

Psychotropic and anticonvulsant drug use by mentally retarded adults across community residential and vocational placements.

J E Martin, M Agran.   

Abstract

The prevalence of psychotropic and anticonvulsant drug use across a comprehensive continuum of community programs for mentally retarded adults was examined. Psychotropic and/or anticonvulsant drugs were administered to 48% of the sample. The hypnotic, antidepressant, antimanic, and anxiolytic medications were used by 6%-12%, the anticonvulsants by 48%, and the neuroleptics by 66% of those who were prescribed psychotropic drugs. Mildly mentally retarded persons used more neuroleptic, manic, and antidepressant medication. Severely and profoundly mentally retarded individuals used more anxiolytics and hypnotic drugs. Psychotropic and anticonvulsant drug intake varied little by sex. However, an institutional history was associated with higher levels of drug use. Seventy percent of those with an institutional history were prescribed drugs; in comparison, only 27% of those without such a history used medication. The percentage of individuals who used psychotropic and anticonvulsant drugs increased dramatically as both the vocational and residential placements became more restrictive. Possible toxic behavioral effects of psychotropic and anticonvulsant medication upon habilitative efforts were discussed. Future research issues were suggested.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2859836     DOI: 10.1016/s0270-3092(85)80020-5

Source DB:  PubMed          Journal:  Appl Res Ment Retard        ISSN: 0270-3092


  3 in total

1.  Prevalence of psychotropic drug use in adults with intellectual disability: positive and negative findings from a large scale study.

Authors:  John A Tsiouris; Soh-Yule Kim; W Ted Brown; Jill Pettinger; Ira L Cohen
Journal:  J Autism Dev Disord       Date:  2013-03

2.  Psychotropic drug treatment among learning-disabled, educable mentally retarded, and seriously emotionally disturbed students.

Authors:  D Cullinan; K D Gadow; M H Epstein
Journal:  J Abnorm Child Psychol       Date:  1987-12

Review 3.  Neuroleptics, learning disability, and the community: some history and mystery.

Authors:  D Manchester
Journal:  BMJ       Date:  1993-07-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.